32 Ill. Adm. Code 335.9030
Training for Uptake, Dilution or Excretion Studies
Section 335
Section 335.9030 Training
for Uptake, Dilution or Excretion Studies
Except as provided in Section
335.9160, a licensee shall require the authorized user of unsealed radioactive
material for the uses authorized under Section 335.3010 not requiring a written
directive to be a physician who:
a) Is certified by a medical specialty board whose certification
process has been recognized by the Agency, the U.S. Nuclear Regulatory
Commission, or an Agreement State. To have its certification process
recognized, a specialty board shall require all candidates for certification to
meet the following requirements:
1) Complete
60 hours of training and experience in basic radionuclide handling techniques
and radiation safety applicable to the medical use of unsealed radioactive
material for uptake, dilution and excretion studies as described in subsections
(c)(1) and (2); and
2) Pass
an examination administered by diplomates of the specialty board, that evaluates
knowledge and competence in radiation safety, radionuclide handling and quality
control; or
b) Is an
authorized user who meets the requirements of Section 335.9040 or 335.9050 or
equivalent U.S. Nuclear Regulatory Commission or Agreement State requirements;
or
c) Has successfully completed a structured educational program
consisting of:
1) 60 hours of training and experience, including a minimum of 8
hours of classroom and laboratory training, in basic radionuclide handling
techniques applicable to the medical use of unsealed radioactive material for
uptake, dilution and excretion studies. The classroom and laboratory training
shall include, at a minimum:
A) Radiation physics and instrumentation;
B) Radiation protection;
C) Mathematics pertaining to the use and measurement of
radioactivity;
D) Chemistry of radioactive material for medical use;
E) Radiation biology; and
2) Work experience under the supervision of an authorized user
who meets the requirements in this Section, Section 335.9040, 335.9050 or
335.9160, or equivalent U.S. Nuclear Regulatory Commission or Agreement State
requirements involving:
A) Ordering,
receiving, and unpacking radioactive materials safely and performing the
related radiation monitoring;
B) Performing
quality control procedures on instruments used to determine the activity of
dosages and performing checks for proper operation of survey instruments;
C) Calculating,
measuring and safely preparing patient or human research subject dosages;
D) Using
administrative controls to prevent a medical event involving the use of
unsealed radioactive material;
E) Using
procedures to contain spilled radioactive material safely and using proper
decontamination procedures; and
F) Administering
dosages of radioactive drugs to patients or human research subjects; and
3) Has
obtained written attestation that the individual has satisfactorily completed
the requirements in subsection (c) and is able to independently fulfill the
radiation safety-related duties as an authorized user for the medical uses
authorized by Section 335.3010. The attestation shall be obtained from either:
A) A
preceptor authorized user who meets the requirements in this Section or Section
335.9040, 335.9050 or 335.9160, or equivalent U.S. Nuclear Regulatory
Commission or Agreement State requirements; or
B) A
residency program director who affirms in writing that the attestation
represents the consensus of the residency program faculty where at least one
faculty member is an authorized user who meets the requirements in this
Section, Sections 335.9040, 335.9050 or 335.9160, or equivalent Agreement State
requirements, and concurs with the attestation provided by the residency
program director. The residency training program shall be approved by the
Residency Review Committee of the Accreditation Council for Graduate Medical
Education, the Royal College of Physicians and Surgeons of Canada, or the Council
on Postdoctoral Training of the American Osteopathic Association and shall
include training and work experience specified in subsections (c)(1) and
(c)(2).
AGENCY NOTE: Specialty boards
whose certification processes have been recognized by the Agency, the U.S.
Nuclear Regulatory Commission or an Agreement State will be posted on the NRC's
website.